Findings

What do systematic reviews say?

12 questions · 12 findings · 3 reviews · Metabolic and Endocrine Disorders

Sort:Best matchNewest Highest certainty Download CSV

No studies found 5 · 41.7%GRADE not reported 0 · 0%Very low 6 · 50%Low 1 · 8.3%Moderate 0 · 0%High 0 · 0%

Metformin vs thiazolidinediones

SAEs

It is very uncertain whether summary of findings of metformin monotherapy for adults with type 2… changes serious adverse events (SAE) compared with thiazolidinediones (very low certainty).

1 finding from 1 review

Metformin monotherapy for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
RR 0.95 [0.84, 1.09]
4 studies · 3208 participants
Very low

Metformin vs dipeptidyl‐peptidase 4 inhibitors

SAEs

1 finding from 1 review

Metformin monotherapy for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 1977 participants
Very low

Metformin vs glucagon like peptide‐1 analogues

SAEs

1 finding from 1 review

Metformin monotherapy for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 807 participants
Very low

Metformin vs sulphonylureas

SAEs

1 finding from 1 review

Metformin monotherapy for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 3081 participants
Very low

Adverse event outcomes for dietary combined with physical activity interventions vs usual care

SAEs · people at increased risk for developing type 2 diabetes

1 finding from 1 review

Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications… 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 250 participants
Low